Breaking News

AMRI Expands Portfolio

To unveil APIs and capabilities at CPhI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI is showcasing its comprehensive portfolio of active pharmaceutical ingredients (APIs) and capabilities at CPhI Worldwide this week. AMRI’s July 2016 acquisition of Euticals positions AMRI as one of the largest independent developers and suppliers of API to the pharmaceutical industry and provides the company with an established presence in key European markets. AMRI provides a broad range of complex API to the life sciences industry, including sterile and high potency APIs, steroid...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters